Variant mouse lymphoma cells with modified response to interferon demonstrate enhanced immunogenicity N. MadorHaya FalkJ. Hochman ORIGINAL ARTICLE Pages: 249 - 256
Efficiency of T cell triggering by anti-CD3 monoclonal antibodies (mAb) with potential usefulness in bispecific mAb generation Nathalie JacobsAlessandra MazzoniSilvana Canevari ORIGINAL ARTICLE Pages: 257 - 264
Induction of multiple anti-c-erbB-2 specificities accompanies a classical idiotypic cascade following 2B1 bispecific monoclonal antibody treatment J. I. ClarkR. Katherine AlpaughL. M. Weiner ORIGINAL ARTICLE Pages: 265 - 272
Gene transfer of a hybrid interleukin-1β gene to B16 mouse melanoma recruits leucocyte subsets and reduces tumour growth in vivo Olle BjörkdahlAnette Gjörloff WingrenM. Dohlsten ORIGINAL ARTICLE Pages: 273 - 281
The participation of the Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependent Shunsuke MoriAnahid JewettB. Bonavida ORIGINAL ARTICLE Pages: 282 - 290
Interleukin-4 is effective in restoring cytotoxic T cell activity that declines during in vivo progression of a murine B lymphoma Sampa SantraS. K. Ghosh ORIGINAL ARTICLE Pages: 291 - 300
Tunnelled central venous catheters yield a low incidence of septicaemia in interleukin-2-treated patients S. H. GoeyJ. VerweijG. Stoter ORIGINAL ARTICLE Pages: 301 - 304